InsidersTradesSigma
Follow the 와이바이오로직스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 와이바이오로직스 has recorded 8 insider filings. Market capitalisation: €135.5bn. The latest transaction was filed on 1 July 2026 (Purchase). Among the most active insiders: 박영우. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
와이바이오로직스 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de productos biofarmacéuticos.